Last 12 months
Inside the activity.
3 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 3 | 0 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2026 Filed Mar 5, 2026 21:30 UTC Amendment |
REICIN ALISEDirector · Chief Executive Officer
|
PurchaseCommon Stock | 2,500 | $21.10 | $52,750.00 |
DisclosureSEC source: 0001757533-26-000008 · form4a-03052026_040323.xml · nonDerivative · entry 1 REICIN ALISE · CIK 0001757533 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 127,030 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.02 to $21.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: These shares are held by the Reicin-Boiarsky Family Trust (the "Trust"). The Reporting Person's spouse is a co-trustee of the Trust. Accordingly, the Reporting Person may be deemed to have shared voting and dispositive power over the securities held by the Trust. The Reporting Person disclaims beneficial ownership of the shares held by the Trust except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| February 10, 2026 Filed Feb 11, 2026 17:32 UTC |
Lochner DanielChief Financial Officer
|
PurchaseCommon Stock | 6,000 | $21.61 | $129,660.00 |
DisclosureSEC source: 0001791187-26-000003 · form4-02112026_100208.xml · nonDerivative · entry 1 Lochner Daniel · CIK 0001791187 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,044 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.24 to $21.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 16:15 UTC |
Schwabish MarcChief Business Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,500 | Not disclosed Strike: $2.38 | Not disclosed |
DisclosureSEC source: 0002023175-26-000003 · form4-02122026_040201.xml · derivative · entry 2 Schwabish Marc · CIK 0002023175 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,014 Underlying: Common Stock · 4,500 shares Expires 2031-06-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Received in exchange for a stock option to acquire 170,679 shares of Tectonic common stock pursuant to that certain merger, as more specifically described in the Reporting Person's Form 4 filed with the Securities and Exchange Commission on June 24, 2024. https://www.sec.gov/Archives/edgar/data/1681087/000141588924017972/xslF345X05/form4-06242024_080616.xml F1 · derivative.exercise_date: The shares subject to the option vest as to 25% of the shares on March 15, 2022 with the remainder vesting in the following 36 equal monthly installments, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 16:15 UTC |
Schwabish MarcChief Business Officer
|
Exercise / conversionCommon Stock | 4,500 | $2.38 | $10,710.00 |
DisclosureSEC source: 0002023175-26-000003 · form4-02122026_040201.xml · nonDerivative · entry 1 Schwabish Marc · CIK 0002023175 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2026 Filed Feb 10, 2026 16:04 UTC |
Lochner DanielChief Financial Officer
|
Tax withholdingCommon Stock | 2,077 | $23.22 | $48,227.94 |
DisclosureSEC source: 0001791187-26-000002 · form4-02102026_090247.xml · nonDerivative · entry 1 Lochner Daniel · CIK 0001791187 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,044 F1 · shares: This transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units granted on February 4, 2025. Read SEC document |
| February 04, 2026 Filed Feb 10, 2026 21:09 UTC |
Ruddy Marcella K.Chief Medical Officer
|
Tax withholdingCommon Stock | 2,064 | $23.22 | $47,926.08 |
DisclosureSEC source: 0002023849-26-000002 · form4-02102026_090218.xml · nonDerivative · entry 1 Ruddy Marcella K. · CIK 0002023849 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,247 F1 · shares: This transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units granted on February 4, 2025. Read SEC document |
| February 04, 2026 Filed Feb 10, 2026 16:10 UTC |
Schwabish MarcChief Business Officer
|
Tax withholdingCommon Stock | 1,619 | $23.22 | $37,593.18 |
DisclosureSEC source: 0002023175-26-000002 · form4-02102026_090237.xml · nonDerivative · entry 1 Schwabish Marc · CIK 0002023175 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,314 F1 · shares: This transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units granted on February 4, 2025. Read SEC document |
| February 04, 2026 Filed Feb 10, 2026 21:06 UTC |
McNamara PeterChief Scientific Officer
|
Tax withholdingCommon Stock | 1,748 | $23.22 | $40,588.56 |
DisclosureSEC source: 0002023255-26-000002 · form4-02102026_090217.xml · nonDerivative · entry 1 McNamara Peter · CIK 0002023255 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,131 F1 · shares: This transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units granted on February 4, 2025. Read SEC document |
| February 04, 2026 Filed Feb 10, 2026 21:07 UTC |
REICIN ALISEDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 4,104 | $23.22 | $95,294.88 |
DisclosureSEC source: 0001757533-26-000004 · form4-02102026_090253.xml · nonDerivative · entry 1 REICIN ALISE · CIK 0001757533 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,047 F1 · shares: This transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units granted on February 4, 2025. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 22:02 UTC |
REICIN ALISEDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,966 | Not disclosed Strike: $2.38 | Not disclosed |
DisclosureSEC source: 0001757533-26-000002 · form4-01052026_100128.xml · derivative · entry 3 REICIN ALISE · CIK 0001757533 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,957 Underlying: Common Stock · 10,966 shares Expires 2031-06-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Received in exchange for a stock option to acquire 63,478 shares of common stock pursuant to that certain merger, as more fully described on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on June 24, 2024. https://www.sec.gov/Archives/edgar/data/1681087/000141588924017952/xslF345X05/form4-06242024_080648.xml F2 · derivative.exercise_date: The shares subject to the option vested as follows: (i) 4,079 shares on June 30, 2024; (ii) 4,078 shares on July 31, 2024, (iii) 4,078 shares on August 31, 2024, (iv) 4,079 shares on September 30, 2024, (v) 4,078 shares on October 31, 2024, (vi) 1,297 shares on November 30, 2024, (vii) 4,078 shares on January 31, 2025, (viii) 4,078 shares on February 28, 2025 and (iv) 4,078 shares on March 31, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date.. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 22:02 UTC |
REICIN ALISEDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 10,966 | $2.38 | $26,099.08 |
DisclosureSEC source: 0001757533-26-000002 · form4-01052026_100128.xml · nonDerivative · entry 1 REICIN ALISE · CIK 0001757533 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,151 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2025 Filed Dec 29, 2025 21:35 UTC |
McNamara PeterChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,000 | Not disclosed Strike: $2.98 | Not disclosed |
DisclosureSEC source: 0002023255-25-000005 · form4-12292025_041201.xml · derivative · entry 2 McNamara Peter · CIK 0002023255 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,065 Underlying: Common Stock · 7,000 shares Expires 2032-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Received in exchange for a stock option to acquire 60,000 shares of common stock pursuant to that certain merger, as more fully described on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on June 24, 2024. https://www.sec.gov/Archives/edgar/data/1681087/000141588924017962/xslF345X05/form4-06242024_080611.xml F1 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on June 27, 2022, subject to the Reporting Person's continued service to the Issuer on each such vesting date. Read SEC document |
| December 22, 2025 Filed Dec 29, 2025 21:35 UTC |
McNamara PeterChief Scientific Officer
|
Exercise / conversionCommon Stock | 7,000 | $2.98 | $20,860.00 |
DisclosureSEC source: 0002023255-25-000005 · form4-12292025_041201.xml · nonDerivative · entry 1 McNamara Peter · CIK 0002023255 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 25, 2025 Filed Sep 29, 2025 17:00 UTC |
Lochner DanielChief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 9,860 | $0.00 Strike: $14.71 | $0.00 |
DisclosureSEC source: 0001791187-25-000003 · form4-09292025_050905.xml · derivative · entry 2 Lochner Daniel · CIK 0001791187 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,860 Underlying: Common Stock · 9,860 shares Expires 2035-09-24 F3 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on October 25, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date. Read SEC document |
| September 25, 2025 Filed Sep 29, 2025 17:00 UTC |
Lochner DanielChief Financial Officer
|
GrantCommon Stock | 5,430 | $0.00 | $0.00 |
DisclosureSEC source: 0001791187-25-000003 · form4-09292025_050905.xml · nonDerivative · entry 1 Lochner Daniel · CIK 0001791187 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,121 F1 · shares: These shares are represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The shares shall vest in 3 equal annual installments on each of September 25, 2026, September 25, 2027 and September 25, 2028, subject to the Reporting Person's continued service to the Issuer on each such vesting date. F2 · balance_after: Please note that the total number of securities beneficially owned following the reported transaction has been corrected to reflect the correct amount. The amount reported on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on February 7, 2025 should have reflected that the total number of securities beneficially owned following the reported transaction was 22,691 shares instead of 4,617 shares. Read SEC document |
| September 25, 2025 Filed Sep 29, 2025 17:00 UTC |
Schwabish MarcChief Business Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 7,650 | $0.00 Strike: $14.71 | $0.00 |
DisclosureSEC source: 0002023175-25-000003 · form4-09292025_050908.xml · derivative · entry 2 Schwabish Marc · CIK 0002023175 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,650 Underlying: Common Stock · 7,650 shares Expires 2035-09-24 F2 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on October 25, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date. Read SEC document |
| September 25, 2025 Filed Sep 29, 2025 17:00 UTC |
Schwabish MarcChief Business Officer
|
GrantCommon Stock | 4,210 | $0.00 | $0.00 |
DisclosureSEC source: 0002023175-25-000003 · form4-09292025_050908.xml · nonDerivative · entry 1 Schwabish Marc · CIK 0002023175 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,933 F1 · shares: These shares are represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The shares shall vest in 3 equal annual installments on each of September 25, 2026, September 25, 2027 and September 25, 2028, subject to the Reporting Person's continued service to the Issuer on each such vesting date. Read SEC document |
| September 25, 2025 Filed Sep 29, 2025 21:00 UTC |
Ruddy Marcella K.Chief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 9,750 | $0.00 Strike: $14.71 | $0.00 |
DisclosureSEC source: 0002023849-25-000003 · form4-09292025_050903.xml · derivative · entry 2 Ruddy Marcella K. · CIK 0002023849 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,750 Underlying: Common Stock · 9,750 shares Expires 2035-09-24 F2 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on October 25, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date. Read SEC document |
| September 25, 2025 Filed Sep 29, 2025 21:00 UTC |
Ruddy Marcella K.Chief Medical Officer
|
GrantCommon Stock | 5,370 | $0.00 | $0.00 |
DisclosureSEC source: 0002023849-25-000003 · form4-09292025_050903.xml · nonDerivative · entry 1 Ruddy Marcella K. · CIK 0002023849 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,311 F1 · shares: These shares are represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The shares shall vest in 3 equal annual installments on each of September 25, 2026, September 25, 2027 and September 25, 2028, subject to the Reporting Person's continued service to the Issuer on each such vesting date. Read SEC document |
| September 25, 2025 Filed Sep 29, 2025 21:00 UTC |
McNamara PeterChief Scientific Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 8,260 | $0.00 Strike: $14.71 | $0.00 |
DisclosureSEC source: 0002023255-25-000003 · form4-09292025_050907.xml · derivative · entry 2 McNamara Peter · CIK 0002023255 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,260 Underlying: Common Stock · 8,260 shares Expires 2035-09-24 F2 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on October 25, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date. Read SEC document |
| September 25, 2025 Filed Sep 29, 2025 21:00 UTC |
McNamara PeterChief Scientific Officer
|
GrantCommon Stock | 4,550 | $0.00 | $0.00 |
DisclosureSEC source: 0002023255-25-000003 · form4-09292025_050907.xml · nonDerivative · entry 1 McNamara Peter · CIK 0002023255 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,879 F1 · shares: These shares are represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The shares shall vest in 3 equal annual installments on each of September 25, 2026, September 25, 2027 and September 25, 2028, subject to the Reporting Person's continued service to the Issuer on each such vesting date. Read SEC document |
| September 25, 2025 Filed Sep 29, 2025 21:00 UTC |
REICIN ALISEDirector · Chief Executive Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 26,710 | $0.00 Strike: $14.71 | $0.00 |
DisclosureSEC source: 0001757533-25-000004 · form4-09292025_050901.xml · derivative · entry 3 REICIN ALISE · CIK 0001757533 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,710 Underlying: Common Stock · 26,710 shares Expires 2035-09-24 F3 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on October 25, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date. Read SEC document |
| September 25, 2025 Filed Sep 29, 2025 21:00 UTC |
REICIN ALISEDirector · Chief Executive Officer
|
GrantCommon Stock | 14,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001757533-25-000004 · form4-09292025_050901.xml · nonDerivative · entry 1 REICIN ALISE · CIK 0001757533 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,185 F1 · shares: These shares are represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The shares shall vest in 3 equal annual installments on each of September 25, 2026, September 25, 2027 and September 25, 2028, subject to the Reporting Person's continued service to the Issuer on each such vesting date. Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 20:55 UTC |
REICIN ALISEDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 859 | $19.81 | $17,016.79 |
DisclosureSEC source: 0001415889-25-018106 · form4-06242025_080636.xml · nonDerivative · entry 1 REICIN ALISE · CIK 0001757533 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,485 F1 · shares: The transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the non-reportable vesting and settlement of restricted stock units granted on December 4, 2024. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:30 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 10,200 | $0.00 Strike: $24.48 | $0.00 |
DisclosureSEC source: 0001415889-25-016672 · form4-06112025_040604.xml · derivative · entry 1 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,200 Underlying: Common Stock · 10,200 shares Expires 2035-06-08 F1 · derivative.exercise_date: The option shall vest in full on the earliest of (i) June 9, 2026, (ii) the date of the Issuer's 2026 Annual Meeting of stockholders, or (iii) a "Change in Control" (as defined in the Issuer's 2024 Equity Incentive Plan) of the Issuer, subject in each case, to the Reporting Person providing continuous service to the Issuer on each such date. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:30 UTC |
MCGUIRE TERRANCEDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,200 | $0.00 Strike: $24.48 | $0.00 |
DisclosureSEC source: 0001415889-25-016674 · form4-06112025_040610.xml · derivative · entry 1 MCGUIRE TERRANCE · CIK 0001117003 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,200 Underlying: Common Stock · 10,200 shares Expires 2035-06-08 F1 · derivative.exercise_date: The option shall vest in full on the earliest of (i) June 9, 2026, (ii) the date of the Issuer's 2026 Annual Meeting of stockholders, or (iii) a "Change in Control" (as defined in the Issuer's 2024 Equity Incentive Plan) of the Issuer, subject in each case, to the Reporting Person providing continuous service to the Issuer on each such date. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:30 UTC |
Tipirneni Praveen P.Director
|
GrantStock Option (Right to Buy) · Derivative | 10,200 | $0.00 Strike: $24.48 | $0.00 |
DisclosureSEC source: 0001415889-25-016673 · form4-06112025_040608.xml · derivative · entry 1 Tipirneni Praveen P. · CIK 0001779978 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,200 Underlying: Common Stock · 10,200 shares Expires 2035-06-08 F1 · derivative.exercise_date: The option shall vest in full on the earliest of (i) June 9, 2026, (ii) the date of the Issuer's 2026 Annual Meeting of stockholders, or (iii) a "Change in Control" (as defined in the Issuer's 2024 Equity Incentive Plan) of the Issuer, subject in each case, to the Reporting Person providing continuous service to the Issuer on each such date. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 16:30 UTC |
Donenberg Phillip B.Director
|
GrantStock Option (Right to Buy) · Derivative | 10,200 | $0.00 Strike: $24.48 | $0.00 |
DisclosureSEC source: 0001415889-25-016676 · form4-06112025_040615.xml · derivative · entry 1 Donenberg Phillip B. · CIK 0001238120 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,200 Underlying: Common Stock · 10,200 shares Expires 2035-06-08 F1 · derivative.exercise_date: The option shall vest in full on the earliest of (i) June 9, 2026, (ii) the date of the Issuer's 2026 Annual Meeting of stockholders, or (iii) a "Change in Control" (as defined in the Issuer's 2024 Equity Incentive Plan) of the Issuer, subject in each case, to the Reporting Person providing continuous service to the Issuer on each such date. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:30 UTC |
Vitorovic StefanDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,200 | $0.00 Strike: $24.48 | $0.00 |
DisclosureSEC source: 0001415889-25-016675 · form4-06112025_040613.xml · derivative · entry 1 Vitorovic Stefan · CIK 0001826967 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,200 Underlying: Common Stock · 10,200 shares Expires 2035-06-08 F1 · derivative.exercise_date: The option shall vest in full on the earliest of (i) June 9, 2026, (ii) the date of the Issuer's 2026 Annual Meeting of stockholders, or (iii) a "Change in Control" (as defined in the Issuer's 2024 Equity Incentive Plan) of the Issuer, subject in each case, to the Reporting Person providing continuous service to the Issuer on each such date. Read SEC document |
| April 11, 2025 Filed Apr 11, 2025 22:12 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
PurchaseCommon Stock | 53,706 | $16.31 | $875,944.86 |
DisclosureSEC source: 0001415889-25-010588 · form4-04112025_100403.xml · nonDerivative · entry 8 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 1,503,358 F4 · price: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $15.96 to $16.68 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F5 · ownership.nature: These shares are held by TAS Partners LLC ("TAS"). The Reporting Person is the sole managing member of TAS and, as such, has sole voting and dispositive power over the shares held by TAS. The Reporting Person disclaims beneficial ownership of the shares held by TAS except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| April 11, 2025 Filed Apr 11, 2025 22:12 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
PurchaseCommon Stock | 9,478 | $16.31 | $154,586.18 |
DisclosureSEC source: 0001415889-25-010588 · form4-04112025_100403.xml · nonDerivative · entry 4 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,334,846 F4 · price: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $15.96 to $16.68 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| April 10, 2025 Filed Apr 11, 2025 22:12 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
PurchaseCommon Stock | 45,858 | $16.73 | $767,204.34 |
DisclosureSEC source: 0001415889-25-010588 · form4-04112025_100403.xml · nonDerivative · entry 7 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 1,449,652 F3 · price: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $16.29 to $17.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F5 · ownership.nature: These shares are held by TAS Partners LLC ("TAS"). The Reporting Person is the sole managing member of TAS and, as such, has sole voting and dispositive power over the shares held by TAS. The Reporting Person disclaims beneficial ownership of the shares held by TAS except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| April 10, 2025 Filed Apr 11, 2025 22:12 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
PurchaseCommon Stock | 8,092 | $16.73 | $135,379.16 |
DisclosureSEC source: 0001415889-25-010588 · form4-04112025_100403.xml · nonDerivative · entry 3 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,325,368 F3 · price: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $16.29 to $17.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| April 09, 2025 Filed Apr 11, 2025 22:12 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
PurchaseCommon Stock | 4,856 | $15.23 | $73,956.88 |
DisclosureSEC source: 0001415889-25-010588 · form4-04112025_100403.xml · nonDerivative · entry 6 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 1,403,794 F2 · price: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $15.1994 to $15.2452 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F5 · ownership.nature: These shares are held by TAS Partners LLC ("TAS"). The Reporting Person is the sole managing member of TAS and, as such, has sole voting and dispositive power over the shares held by TAS. The Reporting Person disclaims beneficial ownership of the shares held by TAS except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| April 09, 2025 Filed Apr 11, 2025 22:12 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
PurchaseCommon Stock | 16,215 | $14.62 | $237,063.30 |
DisclosureSEC source: 0001415889-25-010588 · form4-04112025_100403.xml · nonDerivative · entry 5 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 1,398,938 F1 · price: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $13.9869 to $14.9578 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F5 · ownership.nature: These shares are held by TAS Partners LLC ("TAS"). The Reporting Person is the sole managing member of TAS and, as such, has sole voting and dispositive power over the shares held by TAS. The Reporting Person disclaims beneficial ownership of the shares held by TAS except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| April 09, 2025 Filed Apr 11, 2025 22:12 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
PurchaseCommon Stock | 857 | $15.23 | $13,052.11 |
DisclosureSEC source: 0001415889-25-010588 · form4-04112025_100403.xml · nonDerivative · entry 2 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,317,276 F2 · price: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $15.1994 to $15.2452 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| April 09, 2025 Filed Apr 11, 2025 22:12 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
PurchaseCommon Stock | 2,861 | $14.62 | $41,827.82 |
DisclosureSEC source: 0001415889-25-010588 · form4-04112025_100403.xml · nonDerivative · entry 1 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,316,419 F1 · price: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $13.9869 to $14.9578 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| April 07, 2025 Filed Apr 7, 2025 21:02 UTC |
MCGUIRE TERRANCEDirector
|
SaleCommon Stock | 500,000 | $17.10 | $8,550,000.00 |
DisclosureSEC source: 0000950170-25-051671 · ownership.xml · nonDerivative · entry 1 MCGUIRE TERRANCE · CIK 0001117003 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 573,062 F1 · ownership.nature: The reportable securities are owned directly by Polaris Partners IX, L.P. ("PP IX"). Polaris Partners GP IX, L.L.C. ("PP GP IX") is the general partner of PP IX. Each of David Barrett, Brian Chee, Amir Nashat and Amy Schulman are the managing members of PP GP IX (collectively, the "PP IX GP Managing Members"), and the Reporting Person, a member of the Issuer's board of directors, holds an interest in PP GP IX. Each of PP GP IX, the PP IX GP Managing Members and the Reporting Person, in their respective capacities with respect to PP GP IX, may be deemed to have shared voting, investment and dispositive power with respect to the securities held by PP IX, and each disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| April 07, 2025 Filed Apr 9, 2025 21:38 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
PurchaseCommon Stock | 412,500 | $17.10 | $7,053,750.00 |
DisclosureSEC source: 0001415889-25-010499 · form4-04092025_090407.xml · nonDerivative · entry 2 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 1,382,723 F1 · ownership.nature: These shares are held by TAS Partners LLC ("TAS"). The Reporting Person is the sole managing member of TAS and, as such, has sole voting and dispositive power over the shares held by TAS. The Reporting Person disclaims beneficial ownership of the shares held by TAS except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| April 07, 2025 Filed Apr 9, 2025 21:38 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
PurchaseCommon Stock | 87,500 | $17.10 | $1,496,250.00 |
DisclosureSEC source: 0001415889-25-010499 · form4-04092025_090407.xml · nonDerivative · entry 1 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,313,558 Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 16:19 UTC |
Lochner DanielChief Financial Officer
|
PurchaseCommon Stock | 4,617 | $54.14 | $249,964.38 |
DisclosureSEC source: 0001415889-25-003350 · form4-02072025_090225.xml · nonDerivative · entry 1 Lochner Daniel · CIK 0001791187 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,617 F1 · kind: These shares of common stock were purchased in a private placement transaction on February 5, 2025, which was previously announced on the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on February 3, 2025. These shares were offered and sold in reliance on the exemption afforded by Regulation D of the Securities Act of 1933, as amended. F1 · shares: These shares of common stock were purchased in a private placement transaction on February 5, 2025, which was previously announced on the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on February 3, 2025. These shares were offered and sold in reliance on the exemption afforded by Regulation D of the Securities Act of 1933, as amended. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 21:21 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
PurchaseCommon Stock | 660,000 | $50.00 | $33,000,000.00 |
DisclosureSEC source: 0001415889-25-003351 · form4-02072025_090214.xml · nonDerivative · entry 2 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 970,223 F1 · kind: These shares of common stock were purchased in a private placement transaction on February 5, 2025, which was previously announced on the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on February 3, 2025. These shares were offered and sold in reliance on the exemption afforded by Regulation D of the Securities Act of 1933, as amended. F1 · shares: These shares of common stock were purchased in a private placement transaction on February 5, 2025, which was previously announced on the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on February 3, 2025. These shares were offered and sold in reliance on the exemption afforded by Regulation D of the Securities Act of 1933, as amended. F2 · ownership.nature: These shares are held by TAS Partners LLC ("TAS"). The Reporting Person is the sole managing member of TAS and, as such, has sole voting and dispositive power over the shares held by TAS. The Reporting Person disclaims beneficial ownership of the shares held by TAS except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 21:21 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
PurchaseCommon Stock | 129,294 | $54.14 | $6,999,977.16 |
DisclosureSEC source: 0001415889-25-003351 · form4-02072025_090214.xml · nonDerivative · entry 1 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,226,058 F1 · kind: These shares of common stock were purchased in a private placement transaction on February 5, 2025, which was previously announced on the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on February 3, 2025. These shares were offered and sold in reliance on the exemption afforded by Regulation D of the Securities Act of 1933, as amended. F1 · shares: These shares of common stock were purchased in a private placement transaction on February 5, 2025, which was previously announced on the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on February 3, 2025. These shares were offered and sold in reliance on the exemption afforded by Regulation D of the Securities Act of 1933, as amended. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 16:05 UTC |
Lochner DanielChief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 32,862 | $0.00 Strike: $48.01 | $0.00 |
DisclosureSEC source: 0001415889-25-003227 · form4-02062025_040206.xml · derivative · entry 2 Lochner Daniel · CIK 0001791187 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,862 Underlying: Common Stock · 32,862 shares Expires 2035-02-03 F2 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on March 4, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 16:05 UTC |
Lochner DanielChief Financial Officer
|
GrantCommon Stock | 18,074 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-003227 · form4-02062025_040206.xml · nonDerivative · entry 1 Lochner Daniel · CIK 0001791187 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,074 F1 · shares: These shares are represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The shares shall vest in 3 equal annual installments on each of February 4, 2026, February 4, 2027 and February 4, 2028, subject to the Reporting Person's continued service to the Issuer on each such vesting date. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:05 UTC |
Ruddy Marcella K.Chief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 32,502 | $0.00 Strike: $48.01 | $0.00 |
DisclosureSEC source: 0001415889-25-003226 · form4-02062025_040203.xml · derivative · entry 2 Ruddy Marcella K. · CIK 0002023849 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,502 Underlying: Common Stock · 32,502 shares Expires 2035-02-03 F2 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on March 4, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:05 UTC |
Ruddy Marcella K.Chief Medical Officer
|
GrantCommon Stock | 17,876 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-003226 · form4-02062025_040203.xml · nonDerivative · entry 1 Ruddy Marcella K. · CIK 0002023849 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,941 F1 · shares: These shares are represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The shares shall vest in 3 equal annual installments on each of February 4, 2026, February 4, 2027 and February 4, 2028, subject to the Reporting Person's continued service to the Issuer on each such vesting date. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 16:05 UTC |
Schwabish MarcChief Business Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 25,496 | $0.00 Strike: $48.01 | $0.00 |
DisclosureSEC source: 0001415889-25-003229 · form4-02062025_040210.xml · derivative · entry 2 Schwabish Marc · CIK 0002023175 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,496 Underlying: Common Stock · 25,496 shares Expires 2035-02-03 F2 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on March 4, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 16:05 UTC |
Schwabish MarcChief Business Officer
|
GrantCommon Stock | 14,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-003229 · form4-02062025_040210.xml · nonDerivative · entry 1 Schwabish Marc · CIK 0002023175 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,723 F1 · shares: These shares are represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The shares shall vest in 3 equal annual installments on each of February 4, 2026, February 4, 2027 and February 4, 2028, subject to the Reporting Person's continued service to the Issuer on each such vesting date. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:05 UTC |
McNamara PeterChief Scientific Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 27,530 | $0.00 Strike: $48.01 | $0.00 |
DisclosureSEC source: 0001415889-25-003228 · form4-02062025_040208.xml · derivative · entry 2 McNamara Peter · CIK 0002023255 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,530 Underlying: Common Stock · 27,530 shares Expires 2035-02-03 F2 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on March 4, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.